Exercise of Options & Total Voting Rights

Byotrol

28/04/2021 09:47

RNS Number : 8677W

Byotrol PLC

28 April 2021

 

 

 

 

 

Byotrol Plc

 

("Byotrol" or the "Group")

 

Exercise of Options and Total Voting Rights

 

 

Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that it has allotted a total of 6,765,000 new ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of 6,540,000 options by certain Directors and 225,000 by certain employees below Board level.  Of these, 5,965,000 options were reaching maturity and were due to expire in the current calendar year.

 

All 6,540,000 of the Ordinary Shares issued to the Directors below were subsequently sold at a price of 6.92p. The details of those exercised and sold by such Directors is below:

 

 

Director
Total number of share options exercised
Number of Ordinary Shares sold
Resultant Shareholding
Percentage of the Company's issued share capital held
Remaining number of options held
David Traynor
2,360,000
2,360,000
9,691,142
2.14
2,710,000
Nic Hellyer
800,000
800,000
629,870
0.14
1,200,000
John Langlands
2,700,000
2,700,000
9,000,000
1.99
Nil
Dr Trevor Francis
680,000
680,000
4,470,214
0.99
4,730,000


 

Application has been made for the 6,765,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 5 May 2021.

 

After Admission, the total number of Ordinary Shares in issue will be 453,295,405 and the total number of voting rights will therefore be 453,295,405. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

For further information contact:

 

Byotrol Plc
David Traynor, Chief Executive
+44 (0)1925 742 000
Nic Hellyer, Chief Financial Officer
finnCap Limited (Nominated Adviser and Broker)
+44 (0)20 7220 0500
Geoff Nash/Kate Bannatyne - Corporate Finance
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications
+44 (0)20 7129 1474
Tim Thompson/Andrea Seymour/Fergus Mellon
byotrol@flagstaffcomms.com

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
David Traynor
2.
Reason for the Notification.
a)
Position/status
CEO
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Byotrol plc
b)
LEI
213800AJMTSTIPA59A34
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Ordinary Shares
Identification code
GB00B0999995
b)
Nature of the transaction
Exercise of Options
Sale of Ordinary shares
c)
Price(s) and volume(s)
Exercise Price
Volume(s)
3.50p
360,000
4.125p
2,000,000
Sale Price(s)
Volume(s)
6.92p
2,000,000
6.92p
360,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
27 April 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nic Hellyer
2.
Reason for the Notification.
a)
Position/status
CFO
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Byotrol plc
b)
LEI
213800AJMTSTIPA59A34
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Ordinary Shares
Identification code
GB00B0999995
b)
Nature of the transaction
Exercise of Options
Sale of Ordinary shares
c)
Price(s) and volume(s)
Exercise Price
Volume(s)
2.60p
800,000
Sale Price(s)
Volume(s)
6.92p
800,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
27 April 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
John Langlands
2.
Reason for the Notification.
a)
Position/status
Non-Executive Chairman
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Byotrol plc
b)
LEI
213800AJMTSTIPA59A34
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Ordinary Shares
Identification code
GB00B0999995
b)
Nature of the transaction
Exercise of Options
Sale of Ordinary shares
c)
Price(s) and volume(s)
Exercise Price
Volume(s)
4.125p
2,700,000
Sale Price(s)
Volume(s)
6.92p
2,700,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
27 April 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Trevor Francis
2.
Reason for the Notification.
a)
Position/status
Chief Technology Officer
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Byotrol plc
b)
LEI
213800AJMTSTIPA59A34
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Ordinary Shares
Identification code
GB00B0999995
b)
Nature of the transaction
Exercise of Options
Sale of Ordinary shares
c)
Price(s) and volume(s)
Exercise Price
Volume(s)
3.50p
180,000
4.125p
500,000
Sale Price(s)
Volume(s)
6.92p
180,000
6.92p
500,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
27 April 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

 

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
TVRDKFBQFBKKNQB